Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹153Cr
Rev Gr TTM
Revenue Growth TTM
144.21%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

EY
VS
| Quarter | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | | | 196.1 | 88.5 | 19.4 | 229.3 | 200.4 | 133.6 |
| 2 | 5 | 6 | 5 | 7 | 11 | 8 | 22 | 26 | 29 |
Operating Profit Operating ProfitCr |
| 7.0 | 14.7 | 5.8 | 15.2 | 8.4 | 4.0 | 0.0 | -10.8 | -14.1 | -8.9 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| 0 | 1 | 0 | 1 | 1 | 0 | -1 | -3 | -4 | -4 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | | | | | 183.3 | -82.0 | -273.3 | -518.3 | -1,402.9 | -3,445.4 |
| 4.7 | 10.2 | 4.6 | 13.8 | 4.5 | 1.0 | -6.7 | -17.5 | -19.3 | -13.9 |
| 0.8 | 3.9 | 1.8 | 4.5 | 1.9 | 0.6 | -2.8 | -8.6 | -12.0 | -10.1 |
| Financial Year | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 95.1 | 134.6 |
| 15 | 31 | 84 |
Operating Profit Operating ProfitCr |
| 8.9 | 6.1 | -10.0 |
Other Income Other IncomeCr | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 1 |
Depreciation DepreciationCr | 0 | 0 | 3 |
| 2 | 1 | -12 |
| 0 | 1 | 0 |
|
| | -29.5 | -1,706.5 |
| 6.3 | 2.3 | -15.7 |
| 6.4 | 4.0 | -33.5 |
| Financial Year | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 2 | 2 | 2 |
| 10 | 26 | 26 |
Current Liabilities Current LiabilitiesCr | 2 | 2 | 23 |
Non Current Liabilities Non Current LiabilitiesCr | 0 | 1 | 11 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 10 | 21 | 32 |
Non Current Assets Non Current AssetsCr | 4 | 10 | 27 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | -1 | -1 |
Investing Cash Flow Investing Cash FlowCr | -4 | -15 |
Financing Cash Flow Financing Cash FlowCr | 5 | 15 |
|
Free Cash Flow Free Cash FlowCr | -1 | -1 |
| -52.6 | -140.3 |
CFO To EBITDA CFO To EBITDA% | -37.6 | -52.6 |
| Financial Year | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 175 | 229 |
Price To Earnings Price To Earnings | 164.8 | 304.8 |
Price To Sales Price To Sales | 10.5 | 7.0 |
Price To Book Price To Book | 14.3 | 8.2 |
| 114.3 | 108.5 |
Profitability Ratios Profitability Ratios |
| 36.7 | 43.8 |
| 8.9 | 6.1 |
| 6.3 | 2.3 |
| 12.3 | 4.9 |
| 8.7 | 2.7 |
| 7.6 | 2.4 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
**Eyantra Ventures Limited** (formerly Punit Commercials Limited) is a diversified Indian conglomerate that has undergone a radical strategic transformation. Following a management change in **2022**, the company pivoted from diamond trading to a high-growth multi-vertical model. Today, Eyantra operates at the intersection of **IT Services, Corporate Merchandising, and Healthcare**, leveraging a debt-free balance sheet and aggressive inorganic growth to scale both domestically and internationally.
---
### **Strategic Business Verticals & Revenue Streams**
The company’s revenue is generated through five primary activities, with a strategic shift toward digital platforms and high-margin technology services.
| Vertical | Core Focus & Operations | Key Platforms/Assets |
| :--- | :--- | :--- |
| **Merchandising** | B2B custom merchandise and curated corporate gifting. Transitioned from on-demand fulfillment to a pre-discovery digital model. | **shop.eyantra.com**, **Hamper Story** |
| **IT Services** | AI security, cloud transformation, and digital engineering for US and European markets. | **Prismberry Technologies** |
| **Healthcare** | Specialized neuro and spine hospital services and pharmacy product sales. | **Neuro and Spine Associates (NASAPL)** |
| **Software Services** | Development of RBI-aligned fintech platforms, payments, and Prepaid Instrument (PPI) systems. | Internal IP |
| **Other Services** | Miscellaneous service-linked revenue lines and consulting. | N/A |
---
### **Technology Capabilities: AI, IoT, and Embedded Systems**
Eyantra provides a dual-core service offering designed to bridge the gap between hardware and software, facilitating digital transformation through connected ecosystems.
* **Transformative Software Services:** Focuses on enterprise growth through **Artificial Intelligence (AI)**, custom software engineering, and mobile application development.
* **Embedded and IoT Solutions:** End-to-end support for device connectivity, ranging from **Innovative Product Design** to the implementation of **Embedded Hardware** and **Internet of Things (IoT)** ecosystems.
* **Fintech Integration:** The leadership possesses specialized expertise in obtaining **RBI in-principle approval** for Prepaid Payment Instruments (**PPI**). The company is currently among the largest issuers of **prepaid cards** in India within its specific niche.
---
### **Global Footprint & Subsidiary Structure**
The group has expanded its operational reach through strategic acquisitions and international incorporations to diversify geographic risk.
| Entity Name | Relationship | Purpose & Status |
| :--- | :--- | :--- |
| **Prismberry Technologies Pvt Ltd** | **100%** Subsidiary | Acquired **Aug 2023** for **₹4.20 Cr**; serves as the primary IT delivery engine. |
| **Neuro and Spine Associates Pvt Ltd** | **60%** Subsidiary | Healthcare provider; **₹10.8 Cr** invested for **51.92%** stake as of **June 2025**. |
| **Eyantra Ventures FZE (UAE)** | **100%** Subsidiary | Incorporated **July 2024** in Ajman Free Zone to serve the Middle East. |
| **Eyantra Ventures Inc (USA)** | **100%** Subsidiary | Incorporated **May 2025** in Delaware; hub for international IT and US operations. |
---
### **Financial Trajectory & Capital Efficiency**
Eyantra has demonstrated explosive top-line growth while maintaining a conservative, **debt-free** capital structure.
#### **Comparative Financial Performance**
| Metric (INR in Lakhs/Crores) | FY 2024-25 (Est.) | FY 2023-24 (Consol.) | FY 2022-23 (Stand.) |
| :--- | :--- | :--- | :--- |
| **Total Revenue** | **₹27.59 Cr** | **₹16.76 Cr** | **₹4.97 Cr** |
| **Revenue Growth (YoY)** | **~96%** | **183%** | **214%** |
| **Profit After Tax (PAT)** | *TBD* | **₹0.745 Cr** | **₹0.525 Cr** |
| **Debt-to-Equity Ratio** | **0.00** | **0.00** | **0.00** |
| **Current Ratio** | **10.49x** | *N/A* | *N/A* |
#### **Revenue Segmentation (FY 2023-24)**
* **Merchandise:** **₹1,120.31 Lakhs** (Largest contributor)
* **Services:** **₹555.80 Lakhs**
* **Domestic (India):** **₹1,403.03 Lakhs**
* **International:** **₹273.09 Lakhs**
---
### **Capital Structure & Fundraising Strategy**
The company aggressively utilizes preferential allotments to fund its inorganic growth and working capital requirements without taking on debt.
* **Preferential Allotment (Jan 2025):** Allotted **1,87,500** shares at **₹800** per share (Total: **₹15 Crore**).
* **Fundraising Plan (Nov 2024):** Approved issuance of up to **3,38,343** shares at **₹800** to raise **₹27.07 Crore**.
* **Acquisition Funding (Aug 2023):** Issued **1,75,000** shares via share swap for the **Prismberry** acquisition and **2,04,375** shares at **₹240** for cash.
* **Paid-up Capital:** Stood at **₹2.00 Crore** (divided into **20,06,875** equity shares) as of March 31, 2025.
* **Asset Valuation:** A 2025 third-party valuation of **Prismberry Technologies** at **₹6.21 Crore** (vs. **₹4.2 Crore** book value) resulted in **zero impairment loss** recognized.
---
### **Growth Strategy & Future Outlook**
Eyantra’s roadmap focuses on scaling existing capacities and deepening market penetration:
* **Merchandising Expansion:** Target to increase product listings on **shop.eyantra.com** from **200+** to **1,000+**; deepening presence in **Bangalore, Mumbai, NCR, and Hyderabad**.
* **Healthcare Scaling:** Currently operating **300 beds** across **3** centers; plans to launch a **4th center** (**60-100 beds**) and evaluating further acquisitions in Southern India.
* **Talent Retention:** Launched **EYANTRA ESOP 2025** with a pool of **2,00,000** options to align employee interests with long-term corporate performance.
* **Governance:** The Board maintains **50% independent representation** with expertise spanning banking, finance, and technology. **Mrs. Vinita Raj Narayanam** leads as MD through **2028**.
---
### **Risk Management & Mitigation**
The company operates under a formal Risk Management Policy in compliance with the **Companies Act, 2013** and **SEBI (LODR)**.
| Risk Category | Mitigation Strategy |
| :--- | :--- |
| **Credit Risk** | Managed via **Expected Credit Loss (ECL)** models and rigorous counterparty creditworthiness checks. |
| **Liquidity Risk** | Maintained through a high **Current Ratio (10.49x)** and access to non-fund-based working capital limits. |
| **Market & Interest Risk** | Monitored by the Audit Committee; currently has **zero exposure** to floating rate interest-bearing debt. |
| **Cyber Security** | Integrated into the IT services framework, particularly for fintech and AI operations. |
| **Exchange Rate Risk** | Reported as **zero** for the current period, though this may change as US/UAE operations scale. |